In a letter to CMS Administrator Mehmet Oz, diabetes caucus leaders raised concerns that the agency’s proposals will reduce ...

The global IoT in healthcare market is on track for an unprecedented expansion, transforming the way patients, clinicians, and healthcare systems interact. Estimated to be valued at USD 243.40 billion ...

INDIANAPOLIS, Ind. (Ivanhoe Newswire) - More than 38 million Americans have diabetes and regular blood sugar monitoring is ...

The CGM market is an exciting, fast-growing, multibillion-dollar medtech sector, according to our new Medtech Market ...

People with type 1 diabetes achieved significantly better long-term blood glucose when their levels were monitored by ...

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance ...

Many people are wearing glucose monitors despite them not having diabetes as an approach to weight loss and to improve ...

Kessler Topaz Meltzer & Check, LLP encourages DexCom investors who have suffered significant losses to contact the firm directly to acquire more information. CLICK HERE TO SIGN UP FOR THE CASE OR GO ...

Dexcom Inc. executives may have thought a $30 million beat of the consensus estimates for third quarter revenue and 20% growth year-over-year provided a treat to shareholders, but investors seemed to ...

Medical device company DexCom (NASDAQ:DXCM) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 21.6% year on year to $1.21 billion. The company expects the full ...

Medical device maker Dexcom topped Wall Street estimates for third-quarter results on Thursday, driven by robust demand for its continuous glucose monitoring systems. Interim CEO Jake Leach said the ...

DexCom's stock could drop even more if results falls short of revenue expectations. Whatever happens on Oct. 30, the medical ...